Cargando…

Pharmacological Repression of PPARγ Promotes Osteogenesis

The nuclear receptor peroxisome proliferator-activated receptor gamma (PPARγ) is the master regulator of adipogenesis and the pharmacological target of the thiazolidinedione (TZD) class of insulin sensitizers. Activation of PPARγ by TZDs promotes adipogenesis at the expense of osteoblast formation,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marciano, David P., Kuruvilla, Dana S., Boregowda, Siddaraju V., Asteian, Alice, Hughes, Travis S., Garcia-Ordonez, Ruben, Corzo, Cesar A., Khan, Tanya M., Novick, Scott J., Park, HaJeung, Kojetin, Douglas J., Phinney, Donald G., Bruning, John B., Kamenecka, Theodore M., Griffin, Patrick R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471882/ https://www.ncbi.nlm.nih.gov/pubmed/26068133 http://dx.doi.org/10.1038/ncomms8443

Ejemplares similares

An alternate binding site for PPARγ ligands
por: Hughes, Travis S., et al.
Publicado: (2014)

Definition of functionally and structurally distinct repressive states in the nuclear receptor PPARγ
por: Heidari, Zahra, et al.
Publicado: (2019)

HDX-MS reveals structural determinants for RORγ hyperactivation by synthetic agonists
por: Strutzenberg, Timothy S, et al.
Publicado: (2019)

Correction: HDX-MS reveals structural determinants for RORγ hyperactivation by synthetic agonists
por: Strutzenberg, Timothy S, et al.
Publicado: (2019)

Structural and Dynamic Elucidation of a Non-acid PPARγ Partial Agonist: SR1988
por: Frkic, Rebecca L., et al.
Publicado: (2018)

Quantifiable Metrics for Predicting MSC Therapeutic Efficacy
por: Boregowda, Siddaraju V, et al.
Publicado: (2016)

A molecular switch regulating transcriptional repression and activation of PPARγ
por: Shang, Jinsai, et al.
Publicado: (2020)

A structural mechanism for directing corepressor-selective inverse agonism of PPARγ
por: Brust, Richard, et al.
Publicado: (2018)

PPARG Post-translational Modifications Regulate Bone Formation and Bone Resorption
por: Stechschulte, L.A., et al.
Publicado: (2016)

Identification of Bexarotene as a PPARγ Antagonist with HDX
por: Marciano, David P., et al.
Publicado: (2015)

Defining a conformational ensemble that directs activation of PPARγ
por: Chrisman, Ian M., et al.
Publicado: (2018)

PPARγ in Complex with an Antagonist and Inverse Agonist: a Tumble and Trap Mechanism of the Activation Helix
por: Frkic, Rebecca L., et al.
Publicado: (2018)

Anti-Diabetic Actions of a Non-Agonist PPARγ Ligand Blocking Cdk5-Mediated Phosphorylation
por: Choi, Jang Hyun, et al.
Publicado: (2011)

Structural mechanism for signal transduction in RXR nuclear receptor heterodimers
por: Kojetin, Douglas J., et al.
Publicado: (2015)

A Clinical Indications Prediction Scale Based on TWIST1 for Human Mesenchymal Stem Cells
por: Boregowda, Siddaraju V., et al.
Publicado: (2015)

Transcriptional responses of skeletal stem/progenitor cells to hindlimb unloading and recovery correlate with localized but not systemic multi-systems impacts
por: Booker, Cori N., et al.
Publicado: (2021)

Author Correction: Transcriptional responses of skeletal stem/progenitor cells to hindlimb unloading and recovery correlate with localized but not systemic multi-systems impacts
por: Booker, Cori N., et al.
Publicado: (2021)

IP6K1 Reduces Mesenchymal Stem/Stromal Cell Fitness and Potentiates High Fat Diet‐Induced Skeletal Involution
por: Boregowda, Siddaraju V., et al.
Publicado: (2017)

Novel role for alpha-2-macroglobulin (A2M) as a disease modifying protein in senile osteoporosis
por: Boregowda, Siddaraju V., et al.
Publicado: (2023)

Basal p53 expression is indispensable for mesenchymal stem cell integrity
por: Boregowda, Siddaraju V., et al.
Publicado: (2018)

Obesity-linked phosphorylation of PPARγ by cdk5 is a direct target of the anti-diabetic PPARγ ligands
por: Choi, Jang Hyun, et al.
Publicado: (2010)

Cooperative cobinding of synthetic and natural ligands to the nuclear receptor PPARγ
por: Shang, Jinsai, et al.
Publicado: (2018)

Pharmacological Inhibition of Inositol Hexakisphosphate Kinase 1 Protects Mice against Obesity-Induced Bone Loss
por: Boregowda, Siddaraju V., et al.
Publicado: (2022)

TNP [N2-(m-Trifluorobenzyl), N6-(p-nitrobenzyl)purine] ameliorates diet induced obesity and insulin resistance via inhibition of the IP6K1 pathway
por: Ghoshal, Sarbani, et al.
Publicado: (2016)

Molecular Mechanisms of Host Cytoskeletal Rearrangements by Shigella Invasins
por: Lee, Jun Hyuck, et al.
Publicado: (2014)

Ligand Binding and Activation of PPARγ by Firemaster(®) 550: Effects on Adipogenesis and Osteogenesis in Vitro
por: Pillai, Hari K., et al.
Publicado: (2014)

Osterix represses adipogenesis by negatively regulating PPARγ transcriptional activity
por: Han, Younho, et al.
Publicado: (2016)

Feedback repression of PPARα signaling by Let-7 microRNA
por: Yagai, Tomoki, et al.
Publicado: (2021)

Regulation of Calvarial Osteogenesis by Concomitant De-repression of GLI3 and Activation of IHH Targets
por: Veistinen, Lotta K., et al.
Publicado: (2017)

Rhes protein transits from neuron to neuron and facilitates mutant huntingtin spreading in the brain
por: Ramírez-Jarquín, Uri Nimrod, et al.
Publicado: (2022)

Betulinic acid is a PPARγ antagonist that improves glucose uptake, promotes osteogenesis and inhibits adipogenesis
por: Brusotti, Gloria, et al.
Publicado: (2017)

Structural organization of a major neuronal G protein regulator, the RGS7-Gβ5-R7BP complex
por: Patil, Dipak N, et al.
Publicado: (2018)

Role of Phytoconstituents as PPAR Agonists: Implications for Neurodegenerative Disorders
por: , Sanjay, et al.
Publicado: (2021)

Review of the Structural and Dynamic Mechanisms of PPARγ Partial Agonism
por: Kroker, Alice J., et al.
Publicado: (2015)

TWIST1 and TSG6 are coordinately regulated and function as potency biomarkers in human MSCs
por: Lee, Ryang Hwa, et al.
Publicado: (2023)

Controlled dehydration improves the diffraction quality of two RNA crystals
por: Park, HaJeung, et al.
Publicado: (2016)

Thiophene-Pyrazolourea Derivatives as Potent, Orally Bioavailable, and Isoform-Selective JNK3 Inhibitors
por: Feng, Yangbo, et al.
Publicado: (2020)

Adipocyte-specific Repression of PPAR-gamma by NCoR Contributes to Scleroderma Skin Fibrosis
por: Korman, Benjamin, et al.
Publicado: (2018)

Regulation of Circadian Behavior and Metabolism by Synthetic REV-ERB Agonists
por: Solt, Laura A., et al.
Publicado: (2012)

DNA binding alters coactivator interaction surfaces of the intact VDR–RXR complex
por: Zhang, Jun, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_st11pi1a7722c69v2lhco7gnom